CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Authors
Keywords
CGRP, CGRP antibody, Migraine treatment, Cardiovascular
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 20, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-14
DOI
10.1186/s10194-019-0979-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: Vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity
- (2019) Sara Ellinor Johansson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline
- (2018) Liuyu Zhai et al. JOURNAL OF HYPERTENSION
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects
- (2018) Ahmed N Mahmoud et al. BMJ Open
- Side effects associated with current and prospective antimigraine pharmacotherapies
- (2017) Abimael González-Hernández et al. Expert Opinion on Drug Metabolism & Toxicology
- The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
- (2017) Lars Edvinsson HEADACHE
- CGRP and its receptors
- (2017) Debbie L. Hay et al. HEADACHE
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- The influence of migraine and female hormones on capsaicin-induced dermal blood flow
- (2016) Khatera Ibrahimi et al. CEPHALALGIA
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Migraine and risk of cardiovascular disease in women: prospective cohort study
- (2016) Tobias Kurth et al. BMJ-British Medical Journal
- Migraine and risk of cardiovascular disease in women: prospective cohort study
- (2016) Tobias Kurth et al. BMJ-British Medical Journal
- Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier
- (2015) Sajedeh Eftekhari et al. BRAIN RESEARCH
- CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
- (2015) Lars Edvinsson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies
- (2015) S. Sacco et al. EUROPEAN JOURNAL OF NEUROLOGY
- Endogenous α-calcitonin-gene-related peptide promotes exercise-induced, physiological heart hypertrophy in mice
- (2014) B. Schuler et al. Acta Physiologica
- Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
- (2014) Marcelo E Bigal et al. CEPHALALGIA
- An Ongoing Role of α-Calcitonin Gene–Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
- (2014) Sarah-Jane Smillie et al. HYPERTENSION
- Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
- (2014) Sarah Walter et al. mAbs
- Reduced trigeminovascular cyclicity in patients with menstrually related migraine
- (2014) K. Ibrahimi et al. NEUROLOGY
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Migraine and the Risk for Stroke and Cardiovascular Disease
- (2014) Simona Sacco et al. Current Cardiology Reports
- Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries
- (2013) L. Edvinsson et al. Acta Physiologica
- Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart
- (2013) Mustafa Al-Rubaiee et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Calcitonin-gene related peptide and cerebral vasospasm
- (2013) Karl-Michael Schebesch et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Peripheral vascular dysfunction in migraine: a review
- (2013) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Migraine: the seventh disabler
- (2013) Timothy J Steiner et al. JOURNAL OF HEADACHE AND PAIN
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Migraine and Hemorrhagic Stroke
- (2013) Simona Sacco et al. STROKE
- A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
- (2013) Rosalyne L. Westley et al. International Journal of Endocrinology
- Efficacy, Safety, and Tolerability of Telcagepant in the Treatment of Acute Migraine: A meta-Analysis
- (2013) Xiao-ping Cui et al. Pain Practice
- Migraine and vascular diseases: A review of the evidence and potential implications for management
- (2012) Simona Sacco et al. CEPHALALGIA
- A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
- (2012) B R Chaitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
- (2010) Bart J. Van der Schueren et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
- (2010) S. Eftekhari et al. NEUROSCIENCE
- Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects
- (2010) Kayi Y. Chan et al. PHARMACOLOGY & THERAPEUTICS
- CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
- (2008) J Zeller et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Blood-Brain Barrier in Migraine Treatment
- (2008) L Edvinsson et al. CEPHALALGIA
- Comparison of CGRP and NO Responses in the Human Peripheral Microcirculation of Migraine and Control Subjects
- (2008) M-L Edvinsson et al. CEPHALALGIA
- Calcitonin Gene-Related Peptide Receptor Antagonism Does Not Affect the Severity of Myocardial Ischemia during Atrial Pacing in Dogs with Coronary Artery Stenosis
- (2008) C. P. Regan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started